Mick Ebeling and his team at Not Impossible Labs are revolutionizing healthcare by taking an unorthodox approach to solving problems – from 3D printed prosthetic limbs to helping the deaf hear better at concerts.
Right now, only one company is trying to develop a new type of cell therapy for cancer: Iovance Biotherapeutics, with a market cap of $1.3 billion and 80 employees, and $246 million in the bank.
Health insurers Anthem, Aetna, Humana and UnitedHealth Group are investing in housing, mental health counseling and even food to address “social determinants of health.”
Billionaire investor Carl Icahn now says he will support Cigna’s proposed purchase of Express Scripts, citing recommendations of two influential proxy advisors who came out in favor of the merger.